INNATE PHARMA SP.ADR/1 (IDDA) — Financial Flexibility Index
INNATE PHARMA SP.ADR/1 (IDDA) has a Financial Flexibility Index of -0.36x as of December 2025. Free cash flow of €-30.21 Million (operating CF €-32.56 Million minus capex €2.35 Million) represents 0% of total liabilities (€84.42 Million). Also explore IDDA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
INNATE PHARMA SP.ADR/1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for INNATE PHARMA SP.ADR/1 across 5 annual periods. Check IDDA PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for INNATE PHARMA SP.ADR/1 (2021–2025)
Year-by-year free cash flow to debt coverage for INNATE PHARMA SP.ADR/1. For the full company profile including market capitalisation, see INNATE PHARMA SP.ADR/1 (IDDA) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.36x | €-30.21 Million | €-32.56 Million | €84.42 Million | ▼ -462.3% |
| 2024 | -0.06x | €-6.50 Million | €-6.90 Million | €102.22 Million | ▲ +74.0% |
| 2023 | -0.25x | €-30.21 Million | €-32.56 Million | €123.29 Million | ▼ -97.2% |
| 2022 | -0.12x | €-18.03 Million | €-19.16 Million | €145.14 Million | ▲ +65.2% |
| 2021 | -0.36x | €-57.13 Million | €-58.46 Million | €160.06 Million | — |